Venture Life Group PLC Director/PDMR Shareholding (2871F)
11 Luglio 2019 - 4:33PM
UK Regulatory
TIDMVLG
RNS Number : 2871F
Venture Life Group PLC
11 July 2019
11 July 2019
Venture Life Group plc
("Venture Life" or the "Group")
Director dealings
Venture Life Group plc (AIM: VLG), a leader in developing,
manufacturing and commercialising products for the international
self-care market, announces that Carl Dempsey, Non-Executive
Director, today purchased 20,000 ordinary shares of 0.3 pence each
in the capital of the Company ("Ordinary Shares") at a price of
51.4999 pence per share.
Following this purchase, Mr Dempsey is interested in 20,000
Ordinary Shares, representing approximately 0.02% of the issued
share capital of the Company.
For further information, please contact:
Venture Life Group PLC +44(0) 1344 578004
Jerry Randall, Chief Executive Officer
Cenkos Securities Ltd (Nomad and Broker) +44(0)20 7397 8900
Mark Connelly / Stephen Keys / Cameron
MacRitchie (Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
+44(0)20 3405
Alma PR 0208
Rebecca Sanders-Hewett / Hilary Buchanan / Helena
Bogle / Jessica Joynson
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the global self-care market. With operations in both the UK and
Italy, the Group's product portfolio includes some key products
such as the UltraDEX and Dentyl oral care product ranges, food
supplements for maintaining brain function, medical devices for
women's intimate healthcare and proctology and dermo-cosmetics for
addressing the signs of ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK these are supplied
direct by the company, outside of the UK they are supplied by the
Group's international distribution partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the medical devices and cosmetic
sectors.
The Company makes the following disclosures in accordance with
article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Carl Dempsey
--------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------
a) Position/status Non-Executive Director
--------------------------- -----------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Venture Life Group plc
--------------------------- -----------------------------------
b) LEI 213800S8CZUPLAB2KC70
--------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
----------------------------------------------------------------
a) Description of Ordinary Shares of 0.3p each in
the financial Venture Life Group plc
instrument, type
of instrument
--------------------------- -----------------------------------
b) Identification GB00BFPM8908
code
--------------------------- -----------------------------------
c) Nature of the Purchase of Ordinary Shares
transaction
--------------------------- -----------------------------------
d) Price and volumes Share Purchase
20,000 shares
51.4999 pence
GBP10,299.98
--------------------------- -----------------------------------
d) Aggregated information
- Aggregated N/A - single trade
volume
- Price
--------------------------- -----------------------------------
e) Date of the transaction 11 July 2019
--------------------------- -----------------------------------
f) Place of the London Stock Exchange
transaction
--------------------------- -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFFSDAILLIA
(END) Dow Jones Newswires
July 11, 2019 10:33 ET (14:33 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024